|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | C07D 207/26 | (2006.01) |
| C07D 207/273 | (2006.01) | ||
| C07D 209/52 | (2006.01) | ||
| C07D 215/48 | (2006.01) | ||
| C07D 217/02 | (2006.01) | ||
| C07D 217/22 | (2006.01) | ||
| C07D 217/24 | (2006.01) | ||
| C07D 239/86 | (2006.01) | ||
| C07D 239/88 | (2006.01) | ||
| C07D 263/24 | (2006.01) | ||
| C07D 401/12 | (2006.01) | ||
| C07D 401/14 | (2006.01) | ||
| C07D 403/12 | (2006.01) | ||
| C07D 405/12 | (2006.01) | ||
| C07D 405/14 | (2006.01) | ||
| C07D 413/12 | (2006.01) |
| (11) | Patento numeris | 3126330 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15717250.3 |
| Europos patento paraiškos padavimo data | 2015-03-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-02-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-02-27 |
| (46) | Apibrėžties vertimo paskelbimo data | 2019-04-25 |
| (86) | Numeris | PCT/IB2015/052251 |
| Data | 2015-03-26 |
| (87) | Numeris | WO 2015/150995 |
| Data | 2015-10-08 |
| (30) | Numeris | Data | Šalis |
| 201461975473 P | 2014-04-04 | US |
| (72) |
ANDERSON, David Randolph, US
BUNNAGE, Mark Edward, US
CURRAN, Kevin Joseph, US
DEHNHARDT, Christoph Martin, CA
GAVRIN, Lori Krim, US
GOLDBERG, Joel Adam, US
HAN, Seungil, US
HEPWORTH, David, US
HUANG, Horng-Chih, US
LEE, Arthur, US
LEE, Katherine Lin, US
LOVERING, Frank Eldridge, US
LOWE, Michael Dennis, US
MATHIAS, John Paul, US
PAPAIOANNOU, Nikolaos, US
PATNY, Akshay, US
PIERCE, Betsy Susan, US
SAIAH, Eddine, US
STROHBACH, Joseph Walter, US
TRZUPEK, John David, US
VARGAS, Richard, US
WANG, Xiaolun, US
WRIGHT, Stephen Wayne, US
ZAPF, Christoph Wolfgang, US
|
| (73) |
Pfizer Inc.,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Bicikliniai kondensuoti heteroarilo arba arilo junginiai, ir jų panaudojimas kaip IRAK4 inhibitorių |
| BICYCLIC-FUSED HETEROARYL OR ARYL COMPOUNDS AND THEIR USE AS IRAK4 INHIBITORS |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2024-02-09 | 10 | 231.00 EUR |
| 2025-03-26 |